SESCS develops Health Technology Assessment (HTA) reports requested by various departments of the Canary Health Service (such as a Directorate General, Service, Unit, Hospital, or Management), in accordance with Royal Decree 123/2014 of December 18, which outlines the procedure for implementing health technologies in the clinical practice of the Canary Health Service:
SHORT REPORTS
Short reports are health technology assessment reports requested by a department of the Canary Islands Health Service (General Directorate, Service, Unit, Hospital, Management) and prepared within a period of two to three months.
- Effectiveness, safety, and cost of internal fixation screws in distal metatarsal osteotomy for the treatment of metatarsalgia.
- Report on the efficacy, effectiveness, safety, and cost-effectiveness of dermatoscopy for the diagnosis and clinical follow-up of pigmented skin lesions in primary healthcare.
- Report on the safety, efficacy, and effectiveness of alirocumab and evolocumab in the reduction of long-term cardiovascular events, and budget impact analysis.
During 2015, no requests for health technology assessment reports were received, and the activity focused on responding to specific questions posed by various departments of the Canary Islands Health Service.
- Effectiveness, safety, and cost-effectiveness of the gricode® transfusion safety monitoring system.
- Effectiveness, safety, and efficiency of carmustine implants for the treatment of high-grade gliomas and recurrent glioblastoma multiforme.
- Digital electrocardiogram.
- Current state of scientific knowledge on the effectiveness and safety of using cryopreserved umbilical cord mesenchymal cells for future autologous use.
- Report on the effectiveness and cost-effectiveness of interventions for the treatment of obesity in adults in Primary Care.
- Report on the effectiveness, safety, and budget impact of sperm separation via magnetic columns of annexin V for assisted reproduction.
- Report on the effectiveness, safety, cost-effectiveness, and budget impact of intraosseous access in Primary Healthcare.
- Report on the effectiveness, safety, cost-effectiveness, and acceptability of insulin pen needles.
- Report on the safety, effectiveness, and budget impact of heparin solution for the maintenance of peripheral venous catheters.
- Report on the safety, efficacy, effectiveness, cost, and budget impact of ocriplasmin for vitreomacular traction.
- Centrimag Levitronix® ventricular assist system. Literature review and budget impact.
- Use of nutritional products in patients undergoing bariatric surgery.
- Brilique® for the treatment of acute coronary syndrome.
- Effectiveness and safety of pirfenidone for the treatment of idiopathic pulmonary fibrosis.
- Effectiveness, safety, and cost-effectiveness of ipilimumab in the treatment of advanced melanoma.
- Evaluation of the diagnostic performance of determining the proteins Abeta-42, total Tau, and phosphorylated Tau in cerebrospinal fluid as biomarkers for Alzheimer’s disease.
- New drugs for the treatment of chronic Hepatitis C: Boceprevir (Victrelis®) and Telaprevir (Incivo®).
- Safety, effectiveness, cost-effectiveness, and budget impact of dabigatran etexilate (Pradaxa®).
- Treatment of macular edema caused by retinal vein occlusion: Ozurdex®, Lucentis®.
- Use of magnetic resonance enterography in Crohn’s disease.
- Effectiveness of neuropsychological rehabilitation in patients with acquired brain injury.
- Effectiveness, safety, and cost-effectiveness of hyaluronic acid in the treatment of grade 1-2 knee osteoarthritis and mild-to-moderate hip osteoarthritis.
- Safety, effectiveness, cost, and cost-effectiveness of long-acting injectable olanzapine (Zypadhera®) in the treatment of schizophrenia.
- Scientific evidence on the suitability of implanting nitrous oxide for sedation in a pediatric emergency department.
- Neuromodulation of sacral roots: efficacy, effectiveness, safety, and cost-effectiveness.
- Safety, effectiveness, cost, and cost-effectiveness of zoledronic acid (Aclasta®) in the treatment of osteoporosis.
- Safety, effectiveness, cost-effectiveness, and budget impact of panitumumab (Vectibix®) for metastatic colorectal cancer.
- Effectiveness and cost-effectiveness of peritoneal dialysis.
- Effectiveness and safety of intermittent pneumatic compression devices for the prevention of thromboembolism in patients with contraindications for anticoagulant treatment.
- Effectiveness, safety, and cost-effectiveness of negative pressure wound therapy for the treatment of chronic skin ulcers.
- Scientific evidence on the use of decompressive craniectomy for intracranial pressure control.
- Safety, effectiveness, and cost of eculizumab (Soliris®).
- Safety, effectiveness, cost, and cost-effectiveness of treprostinil (Remodulin®) in the treatment of pulmonary arterial hypertension.
- Safety, effectiveness, cost-effectiveness, and budget impact of temsirolimus (Torisel®).
- Safety, effectiveness, cost-effectiveness, and budget impact of bevacizumab (Avastin®) for metastatic breast cancer.
- Trypsone® for the treatment of emphysema due to alpha-1 antitrypsin deficiency: safety, effectiveness, cost-effectiveness, and budget impact.
IMMEDIATE RESPONSE
Immediate response short reports are health technology assessment reports requested by a department of the Canary Islands Health Service (General Directorate, Service, Unit, Hospital, Management) and are prepared in less than a month. They are prepared in a short space of time and are called immediate response due to the need to make a prompt health policy decision and/or because there is no uncertainty about the scientific evidence.
- Rapid report on the efficacy, effectiveness, safety, and cost-effectiveness of using phenytoin to manage status epilepticus (2nd line) in primary health care.
- Report on the efficacy, effectiveness, safety, and cost-effectiveness of preoperative use of antiseptics to reduce the risk of surgical site infections.
- Cost-effectiveness of neonatal screening for Pompe disease using tandem mass spectrometry. Potential budgetary impact in the Canary Islands.
- Evaluation of sterilization systems.
- Scientific evidence on the suitability of implementing home iontophoresis as a new service at the Insular-Materno Infantil University Hospital Complex.
